Clinical trial Recruiting at 1 site Observational Ages 35 to 65 Women only

Using cardiac MRI to study healthy women for heart disease insights

Official title: Cardiac Magnetic Resonance Imaging Normal Reference Control Group Testing - Ancillary Study to Coronary Endothelial Function and Microvascular Disease in Women

Run by Cedars-Sinai Medical Center · NCT00573339 · Data updated 2026-11-12

This study is testing how cardiac MRI can help us learn more about heart health in healthy women to improve diagnosis and treatment for women with small artery heart disease.

More Healthy Aging trials

Quick facts

Study typeObservational
Ages35 Years to 65 Years
SexWomen only
Enrollment20 (estimated)
SponsorCedars-Sinai Medical Center
Academic / other
Locations1 site (Los Angeles, California)
StatusRecruiting
StartedMay 2007
Main results expectedDecember 2030
Study endsDecember 2030
Registry record updatedSeptember 1, 2023
Trial IDNCT00573339 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy women without any signs or symptoms of heart disease.

Probably not a fit

Patients with existing heart disease or those who do not meet the inclusion criteria will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research aims to apply cardiac magnetic resonance imaging (CMR) to women without heart disease to establish a normal reference control group. The study will enroll 40 healthy women who will undergo various assessments, including exercise treadmill tests and CMR scans, to gather data on cardiovascular health. By comparing these results to those of women with small artery heart disease, the study seeks to enhance understanding of CMR's utility in diagnosing and treating this condition. The findings may lead to improved noninvasive diagnostic techniques for women suffering from small vessel heart disease.

Why it matters

Potential benefit: If successful, this study could lead to better diagnostic methods for small artery heart disease in women, potentially improving treatment outcomes.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in using advanced imaging techniques for cardiovascular assessment.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Women without signs and symptoms of myocardial ischemia (chest pain, abnormal stress testing, abnormal noninvasive testing).
2. No cardiac risk factors by Framingham/NCEP criteria, age and BMI matched to the Cardiac Syndrome X population, and a normal exercise stress test.

Exclusion Criteria:

1. Contraindications to CMR testing (metal devices in chest, claustrophobia, known angioedema).
2. Contraindication to Adenosine or Lexiscan (regadenoson) including heart block (second and third degree) and sinus node disease, significant COPD/asthma, or systemic hypotension (\<90 mmHg).
3. Contraindication to Dobutamine including severe systemic hypertension (≥ 220/120 mmHg), unstable angina, significant aortic valve stenosis, complex cardiac arrhythmia including uncontrolled atrial fibrillation, hypertrophic obstructive cardiomyopathy, myocarditis, endocarditis, pericarditis, or uncontrolled congestive heart failure.
4. Contraindication to Gadolinium (renal impairment).
5. Any renal disease.
6. Pregnant and lactating women.
7. Inability to perform exercise, eg. orthopedic limitations.
8. Allergy to animal dander.

Where it's running

  • Cedars-Sinai Women's Heart Center
    Los Angeles, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.